Loading...
XJPX
7447
Market cap366mUSD
Dec 05, Last price  
1,867.00JPY
1D
-0.59%
1Q
-7.53%
Jan 2017
-26.81%
IPO
133.38%
Name

Nagaileben Co Ltd

Chart & Performance

D1W1MN
XJPX:7447 chart
P/E
20.16
P/S
3.47
EPS
92.59
Div Yield, %
3.21%
Shrs. gr., 5y
-0.89%
Rev. gr., 5y
-0.45%
Revenues
16.41b
-4.48%
14,329,355,00014,340,873,00014,221,827,00013,632,939,00013,669,591,00014,076,158,00014,578,251,00015,175,301,00015,625,092,00016,214,170,00016,150,534,00016,537,600,00017,017,288,00017,144,788,00016,785,667,00017,066,476,00017,563,397,00017,745,488,00017,181,958,00016,412,661,000
Net income
2.82b
-12.53%
2,146,873,0002,272,132,0002,305,612,0002,094,257,0001,516,269,0002,344,384,0002,493,825,0002,371,947,0003,119,278,0003,224,020,0003,225,962,0003,262,039,0003,673,338,0003,675,995,0003,445,153,0003,474,081,0003,647,873,0003,778,265,0003,226,360,0002,822,054,000
CFO
2.29b
+26.15%
2,699,572,0001,911,402,0002,349,227,0001,807,791,0002,518,938,0002,840,915,0003,050,799,0002,919,158,0002,736,778,0003,271,079,0002,727,887,0003,565,352,0003,979,490,0004,009,674,0003,433,275,0003,634,632,0004,448,944,0003,442,608,0001,812,783,0002,286,800,000
Dividend
Aug 28, 20250 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Nagaileben Co., Ltd. produces and sells medical clothing in Japan. It offers hospital, clinic, and operation room wear products. The company was founded in 1915 and is headquartered in Tokyo, Japan.
IPO date
Aug 10, 2001
Employees
524
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑082023‑082022‑082021‑082020‑082019‑082018‑082017‑082016‑08
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT